Amicus Therapeutics
FOLD
#3908
Rank
HK$23.77 B
Marketcap
HK$77.07
Share price
-0.50%
Change (1 day)
1.47%
Change (1 year)

Amicus Therapeutics (FOLD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$4.96 Billion

According to Amicus Therapeutics 's latest financial reports the company's total liabilities are HK$4.96 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Amicus Therapeutics - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$4.58 B-4.9%
2023-12-31HK$4.82 B2.72%
2022-12-31HK$4.69 B0.76%
2021-12-31HK$4.66 B0.19%
2020-12-31HK$4.65 B59.82%
2019-12-31HK$2.91 B-16.84%
2018-12-31HK$3.50 B63.42%
2017-12-31HK$2.14 B-59.18%
2016-12-31HK$5.24 B20.78%
2015-12-31HK$4.34 B538.05%
2014-12-31HK$0.68 B7.34%
2013-12-31HK$0.63 B100.27%
2012-12-31HK$0.31 B1.45%
2011-12-31HK$0.31 B-15.74%
2010-12-31HK$0.37 B253.05%
2009-12-31HK$0.10 B-76.47%
2008-12-31HK$0.44 B-10.32%
2007-12-31HK$0.49 B-53.37%
2006-12-31HK$1.06 B113.32%
2005-12-31HK$0.50 B
2003-12-31HK$44.77 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
HK$85.63 B 1,623.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$12.12 B 144.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$6.34 B 27.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$477.07 B 9,499.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
HK$0.66 B-86.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$419.11 B 8,333.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark